ArticleEuropean journal of nuclear medicine and molecular imaging2011

Early assessment of tumor response to JAC106, an anti-tubulin agent, by 3'-deoxy-3'-[¹⁸F]fluorothymidine in preclinical tumor models.

Seung Jin Lee et al.PubMed ↗Publisher ↗

No numbers read from the abstract.